Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $74,489.82 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 1,257 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $59.26, for a total transaction of $74,489.82. Following the completion of the transaction, the chief financial officer now directly owns 21,358 shares of the company’s stock, valued at $1,265,675.08. This represents a 5.56 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Kewaunee Scientific Price Performance

NASDAQ KEQU opened at $58.39 on Thursday. The company has a 50 day simple moving average of $49.63 and a 200-day simple moving average of $45.26. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $67.20. The firm has a market capitalization of $167.70 million, a price-to-earnings ratio of 9.25 and a beta of 0.72. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP increased its stake in shares of Kewaunee Scientific by 3.6% in the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after acquiring an additional 6,132 shares during the last quarter. Renaissance Technologies LLC grew its stake in Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after purchasing an additional 10,580 shares in the last quarter. Heron Bay Capital Management purchased a new position in Kewaunee Scientific in the second quarter valued at about $252,000. Ritholtz Wealth Management raised its stake in shares of Kewaunee Scientific by 24.6% during the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after purchasing an additional 2,156 shares in the last quarter. Finally, De Lisle Partners LLP raised its stake in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after purchasing an additional 11,511 shares in the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.